Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1425)
  3. Review (81)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3379)
  2. Solid Tumor Oncology Division (3379)
  3. GSK Faculty (1068)
  4. Department of Pathology and Laboratory Medicine (806)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (659)
  6. Human Oncology and Pathogenesis Program (633)

More Groups

People
  1. Mark Kris (870)
  2. Alexander Drilon (634)
  3. Gregory Riely (602)
  4. Charles Rudin (493)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (99)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (701)
  2. Journal of Thoracic Oncology (514)
  3. Annals of Oncology (277)
  4. Clinical Cancer Research (157)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (780)
  2. Elsevier Inc. (735)
  3. American Association for Cancer Research (385)
  4. Oxford University Press (351)
  5. Nature Publishing Group (154)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3379)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Final results from the phase Ia/Ib study of the novel bromodomain and extra-terminal domain inhibitor, BI 894999, in patients with advanced solid tumors or diffuse large B-cell lymphoma
    Journal Article

    Lauer, U. M.; Awada, A.; Postel-Vinay, S.; Shapiro, G. I.; Thieblemont, C.; Piha-Paul, S. A.; Paik, P. K.; Shepard, D. R.; Docampo, L. I.; Galot, R.; more...
    ESMO Open (2025)

    Fulltext@MSK | Save
  • From knowledge to action: The journey toward targeting the MET pathway via MET exon 14 skipping
    Review

    Bogdanska, W.; Paik, P. K.
    Cancer (2025)

    Fulltext@MSK | Save
  • Targeting ROS1 rearrangements in non–small cell lung cancer: Current insights and future directions
    Review

    Desilets, A.; Repetto, M.; Yang, S. R.; Drilon, A.
    Cancer (2025)

    Fulltext@MSK | Save
  • Targeting HER2 in lung cancers: Evolving treatment landscape and drug development strategies
    Review

    Reinhorn, D.; Moskovitz, M.; Tap, W. D.; Li, B. T.
    Cancer (2025)

    Fulltext@MSK | Save
  • Population-adjusted indirect treatment comparisons of repotrectinib among patients with ROS1+ NSCLC
    Journal Article

    Wolf, J.; Goring, S.; Lee, A.; Cho, B. C.; Drilon, A.; Yuan, Y.; Ayers, D.; Lozano-Ortega, G.; Korol, E. E.; Korpach, S. G.; more...
    Cancers (2025)

    Fulltext@MSK | Save
  • The clinical TIL experience in melanoma: Past, present, future
    Review

    Smithy, J. W.; Schoenfeld, A. J.; Betof Warner, A.
    Transplantation and Cellular Therapy (2025)

    Fulltext@MSK | Save
  • A podcast discussion on the intracranial efficacy of antibody–Drug conjugates in patients with EGFR-mutated NSCLC with brain metastases
    Editorial

    Johnson, M. L.; Lin, J. J.; Boire, A.; Khandekar, M. J.; Yu, H. A.
    Oncology and Therapy (2025)

    Fulltext@MSK | Save
  • REZILIENT3: Randomized phase III study of first-line zipalertinib plus chemotherapy in patients with EGFR exon 20 insertion-mutated NSCLC
    Journal Article

    Heymach, J. V.; Yu, H. A.; Besse, B.; Cheng, Y.; Tan, D. S. W.; Wei, L.; Wacheck, V.; Nishio, M.
    Future Oncology (2025)

    Fulltext@MSK | Save
  • Efficacy and safety of larotrectinib in patients with TRK fusion gastrointestinal cancer
    Journal Article

    Qi, C.; Shen, L.; Andre, T.; Chung, H. C.; Cannon, T. L.; Garralda, E.; Italiano, A.; Rieke, D. T.; Liu, T.; Burcoveanu, D. I.; more...
    European Journal of Cancer (2025)

    Fulltext@MSK | Save
  • A phase 1 study of the combination of BH3-mimetic, navitoclax, and mTORC1/2 inhibitor, vistusertib, in patients with advanced solid tumors
    Journal Article

    Scott, S. C.; Farago, A.; Lai, W. V.; Zahurak, M.; Rudek, M. A.; Murray, J.; Carducci, M. A.; Uziel, T.; Takebe, N.; Gore, S. D.; more...
    Cancer Chemotherapy and Pharmacology (2025)

    Fulltext@MSK | Save